Edition:
United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

13.49CNY
2:28am EDT
Change (% chg)

¥0.09 (+0.67%)
Prev Close
¥13.40
Open
¥13.56
Day's High
¥13.80
Day's Low
¥13.45
Volume
7,432,722
Avg. Vol
11,947,977
52-wk High
¥42.55
52-wk Low
¥13.00

300147.SZ

Chart for 300147.SZ

About

Xiangxue Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of Chinese patent medicine. The Company provides tablets, capsules, granules, oral liquids and aerosols, among others. The Company's major products include antiviral oral liquids and indigowoad root granules. The Company distributes its... (more)

Overall

Beta: 0.86
Market Cap(Mil.): ¥9,035.77
Shares Outstanding(Mil.): 661.48
Dividend: 0.12
Yield (%): 0.82

Financials

  300147.SZ Industry Sector
P/E (TTM): 51.61 34.43 35.43
EPS (TTM): 0.26 -- --
ROI: 6.13 13.73 13.09
ROE: 6.52 14.71 14.22

BRIEF-Xiangxue Pharma plans medical investment fund, unit to invest in Chinese medicine project

* Says plans to set up medical and healthcare investment fund of size 1 billion yuan ($154.40 million) with partners

May 03 2016

BRIEF-Xiangxue Pharma to issue up to 2.5 bln yuan medium-term notes, commercial paper

* Says plans to issue up to 1 billion yuan ($153.20 million)medium-term notes, up to 1.5 billion yuan commercial paper

Feb 23 2016

BRIEF-Xiangxue Pharma's unit to invest in Chuangmei's Hong Kong stock offer

* Says Hong Kong unit signs agreement to invest HK$31 million ($4.00 million) in Chuangmei Pharmaceutical's stock offering in Hong Kong

Dec 02 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.